snip.
← Back to Home ID: 50435
TOGA @togaanz.bsky.social
Jul 11, 03:10 PM

Episode 1 of our special two-part Conversations in Lung Cancer Research series explores one of the most significant changes to immunotherapy access in Australia. In this episode, the panel discusses the landmark PBS listing of ipilimumab and nivolumab,

🎤 Whisper Transcript (en) ⏱ 24s

"So the broadening of the listing of ipilimumab and nivolumab to cover immunotherapy sensitive, advanced, or metastatic disease indications was made available from the 1st of March this year in Australia. And as a global first, removed that tumor type siloing, allowing prescribing based on clinical judgment and best available evidence for the patient we have in front of us."

💬 Discussion

TOGA @togaanz.bsky.social · Jul 9, 11:01 PM

Episode 1 of our special two-part Conversations in Lung Cancer Research series explores one of the most significant changes to immunotherapy access in Australia. In this episode, the panel discusses the landmark PBS listing of ipilimumab and nivolumab,

<div class="border-l-2 border-slate-800/60 pl-4 py-2 mt-3 ml-2"> <div class="flex items-start gap-2.5"> <!-- Avatar --> <img src="https://cdn.bsky.app/img/avatar/plain/did:plc:7jhpmq23tkwbluvrqmzvu5lq/bafkreibywh5s6cxqmvjibpaesz22l736mf65y3oxikeczblqy6xv567vbm" class="w-6 h-6 rounded-full shrink-0 border border-slate-800" /> <!-- Comment Content --> <div class="flex-1 min-w-0"> <div class="flex items-center gap-2 mb-1"> <span class="text-xs font-bold text-slate-300">TOGA</span> <span class="text-[10px] text-slate-500">@togaanz.bsky.social</span> <span class="text-[9px] text-slate-600">· Jul 9, 11:01 PM</span> </div> <p class="text-xs text-slate-350 leading-relaxed break-words">which moved beyond tumour-specific restrictions and introduced a more flexible, evidence-based approach to prescribing. This podcast is sponsored by Bristol Myers Squibb. Listen on Apple &amp;gt; buff.ly/SRwVG1V Spotify &amp;gt; buff.ly/dqB71SY Show notes &amp;gt; buff.ly/LUIDaIc</p> </div> </div> <!-- Replies --> </div>